Logo image of CRL.MI

CAREL INDUSTRIES SPA (CRL.MI) Stock Fundamental Analysis

BIT:CRL - Euronext Milan - IT0005331019 - Common Stock - Currency: EUR

18.38  -0.16 (-0.86%)

Fundamental Rating

6

Taking everything into account, CRL scores 6 out of 10 in our fundamental rating. CRL was compared to 18 industry peers in the Building Products industry. CRL scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, CRL is valued expensive at the moment. These ratings would make CRL suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CRL had positive earnings in the past year.
CRL had a positive operating cash flow in the past year.
CRL had positive earnings in each of the past 5 years.
In the past 5 years CRL always reported a positive cash flow from operatings.
CRL.MI Yearly Net Income VS EBIT VS OCF VS FCFCRL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

With an excellent Return On Assets value of 7.36%, CRL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
CRL's Return On Equity of 14.40% is amongst the best of the industry. CRL outperforms 88.89% of its industry peers.
The Return On Invested Capital of CRL (7.81%) is better than 66.67% of its industry peers.
CRL had an Average Return On Invested Capital over the past 3 years of 11.78%. This is significantly above the industry average of 5.60%.
Industry RankSector Rank
ROA 7.36%
ROE 14.4%
ROIC 7.81%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
CRL.MI Yearly ROA, ROE, ROICCRL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CRL has a Profit Margin of 10.83%. This is amongst the best in the industry. CRL outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of CRL has remained more or less at the same level.
CRL's Operating Margin of 11.50% is amongst the best of the industry. CRL outperforms 100.00% of its industry peers.
CRL's Operating Margin has declined in the last couple of years.
CRL's Gross Margin of 44.65% is fine compared to the rest of the industry. CRL outperforms 72.22% of its industry peers.
CRL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.5%
PM (TTM) 10.83%
GM 44.65%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
CRL.MI Yearly Profit, Operating, Gross MarginsCRL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CRL is creating some value.
The number of shares outstanding for CRL remains at a similar level compared to 1 year ago.
Compared to 5 years ago, CRL has more shares outstanding
CRL has a better debt/assets ratio than last year.
CRL.MI Yearly Shares OutstandingCRL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CRL.MI Yearly Total Debt VS Total AssetsCRL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CRL has an Altman-Z score of 4.86. This indicates that CRL is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.86, CRL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
CRL has a debt to FCF ratio of 2.84. This is a good value and a sign of high solvency as CRL would need 2.84 years to pay back of all of its debts.
CRL has a Debt to FCF ratio of 2.84. This is amongst the best in the industry. CRL outperforms 94.44% of its industry peers.
CRL has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
CRL's Debt to Equity ratio of 0.25 is amongst the best of the industry. CRL outperforms 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.84
Altman-Z 4.86
ROIC/WACC0.97
WACC8.02%
CRL.MI Yearly LT Debt VS Equity VS FCFCRL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

CRL has a Current Ratio of 1.88. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.88, CRL belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that CRL should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.34, CRL is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.34
CRL.MI Yearly Current Assets VS Current LiabilitesCRL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for CRL have decreased strongly by -19.15% in the last year.
Measured over the past years, CRL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.70% on average per year.
CRL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.03%.
The Revenue has been growing by 12.06% on average over the past years. This is quite good.
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%90.91%
Revenue 1Y (TTM)-11.03%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%-4.83%

3.2 Future

The Earnings Per Share is expected to grow by 11.88% on average over the next years. This is quite good.
CRL is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.38% yearly.
EPS Next Y-1.98%
EPS Next 2Y8.48%
EPS Next 3Y11.88%
EPS Next 5YN/A
Revenue Next Year8.55%
Revenue Next 2Y8.92%
Revenue Next 3Y8.38%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRL.MI Yearly Revenue VS EstimatesCRL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CRL.MI Yearly EPS VS EstimatesCRL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.82, CRL can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CRL is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 28.10, CRL is valued at the same level.
A Price/Forward Earnings ratio of 33.48 indicates a quite expensive valuation of CRL.
Based on the Price/Forward Earnings ratio, CRL is valued a bit more expensive than 66.67% of the companies in the same industry.
CRL is valuated expensively when we compare the Price/Forward Earnings ratio to 20.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 32.82
Fwd PE 33.48
CRL.MI Price Earnings VS Forward Price EarningsCRL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

77.78% of the companies in the same industry are cheaper than CRL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRL indicates a slightly more expensive valuation: CRL is more expensive than 61.11% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 38.44
EV/EBITDA 20.34
CRL.MI Per share dataCRL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

CRL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.38
EPS Next 2Y8.48%
EPS Next 3Y11.88%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.93%, CRL is not a good candidate for dividend investing.
CRL's Dividend Yield is slightly below the industry average, which is at 2.26.
With a Dividend Yield of 0.93, CRL pays less dividend than the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 0.93%

5.2 History

The dividend of CRL is nicely growing with an annual growth rate of 14.04%!
Dividend Growth(5Y)14.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

CRL pays out 34.12% of its income as dividend. This is a sustainable payout ratio.
The dividend of CRL is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP34.12%
EPS Next 2Y8.48%
EPS Next 3Y11.88%
CRL.MI Yearly Income VS Free CF VS DividendCRL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRL.MI Dividend Payout.CRL.MI Dividend Payout, showing the Payout Ratio.CRL.MI Dividend Payout.PayoutRetained Earnings

CAREL INDUSTRIES SPA

BIT:CRL (5/6/2025, 11:27:29 AM)

18.38

-0.16 (-0.86%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)03-13 2025-03-13/dmh
Earnings (Next)05-13 2025-05-13
Inst Owners31.3%
Inst Owner ChangeN/A
Ins Owners52.75%
Ins Owner ChangeN/A
Market Cap2.07B
Analysts71.11
Price Target19.79 (7.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.93%
Yearly Dividend0.19
Dividend Growth(5Y)14.04%
DP34.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)65.02%
Min EPS beat(2)-0.99%
Max EPS beat(2)131.02%
EPS beat(4)2
Avg EPS beat(4)35.95%
Min EPS beat(4)-9.99%
Max EPS beat(4)131.02%
EPS beat(8)6
Avg EPS beat(8)22.84%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.12%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)-1.82%
Revenue beat(4)0
Avg Revenue beat(4)-4.49%
Min Revenue beat(4)-6.54%
Max Revenue beat(4)-1.82%
Revenue beat(8)4
Avg Revenue beat(8)-1.74%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)4.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.2%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.06%
Revenue NY rev (3m)-2.87%
Valuation
Industry RankSector Rank
PE 32.82
Fwd PE 33.48
P/S 3.57
P/FCF 38.44
P/OCF 24.22
P/B 4.75
P/tB 37.46
EV/EBITDA 20.34
EPS(TTM)0.56
EY3.05%
EPS(NY)0.55
Fwd EY2.99%
FCF(TTM)0.48
FCFY2.6%
OCF(TTM)0.76
OCFY4.13%
SpS5.14
BVpS3.87
TBVpS0.49
PEG (NY)N/A
PEG (5Y)3.38
Profitability
Industry RankSector Rank
ROA 7.36%
ROE 14.4%
ROCE 9.8%
ROIC 7.81%
ROICexc 9.19%
ROICexgc 26.97%
OM 11.5%
PM (TTM) 10.83%
GM 44.65%
FCFM 9.3%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
ROICexc(3y)15.05%
ROICexc(5y)17.4%
ROICexgc(3y)43.53%
ROICexgc(5y)43.91%
ROCE(3y)14.8%
ROCE(5y)15.83%
ROICexcg growth 3Y-17.51%
ROICexcg growth 5Y-0.61%
ROICexc growth 3Y-24.29%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 2.84
Debt/EBITDA 1.04
Cap/Depr 82.41%
Cap/Sales 5.46%
Interest Coverage 15.77
Cash Conversion 81.42%
Profit Quality 85.86%
Current Ratio 1.88
Quick Ratio 1.34
Altman-Z 4.86
F-Score6
WACC8.02%
ROIC/WACC0.97
Cap/Depr(3y)91.98%
Cap/Depr(5y)87.52%
Cap/Sales(3y)4.87%
Cap/Sales(5y)4.61%
Profit Quality(3y)86.55%
Profit Quality(5y)91.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%90.91%
EPS Next Y-1.98%
EPS Next 2Y8.48%
EPS Next 3Y11.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.03%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%-4.83%
Revenue Next Year8.55%
Revenue Next 2Y8.92%
Revenue Next 3Y8.38%
Revenue Next 5YN/A
EBIT growth 1Y-36.28%
EBIT growth 3Y1.26%
EBIT growth 5Y7.88%
EBIT Next Year85.59%
EBIT Next 3Y32.19%
EBIT Next 5YN/A
FCF growth 1Y-27.92%
FCF growth 3Y14.88%
FCF growth 5Y15.64%
OCF growth 1Y-16.31%
OCF growth 3Y16.42%
OCF growth 5Y11.49%